{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T07:02:43Z","timestamp":1775458963592,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":188,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004635","name":"Fru Berta Kamprads Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004635","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Governmental Funding of Clinical Reserach within the National Helat Service"},{"DOI":"10.13039\/100016874","name":"LMK foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016874","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016874","name":"LMK Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016874","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1038\/s41379-022-01012-y","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T13:07:33Z","timestamp":1644930453000},"page":"979-988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Delineating the intra-patient heterogeneity of molecular alterations in treatment-na\u00efve colorectal cancer with peritoneal carcinomatosis"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1728-5092","authenticated-orcid":false,"given":"Christina","family":"Siesing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Petersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thora","family":"Ulfarsdottir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhayan","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Nodin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Eberhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Br\u00e4ndstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingvar","family":"Syk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gisselsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Jirstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-022-01012-y_bib1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.8679","article-title":"Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer","volume":"99","author":"Segelman","year":"2012","journal-title":"Br. J. Surg."},{"key":"10.1038\/s41379-022-01012-y_bib2","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/ijc.25596","article-title":"Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: A population-based study","volume":"128","author":"Lemmens","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1038\/s41379-022-01012-y_bib3","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","article-title":"Peritoneal carcinomatosis from colorectal cancer","volume":"89","author":"Jayne","year":"2002","journal-title":"Br. J. Surg."},{"key":"10.1038\/s41379-022-01012-y_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01274232","article-title":"Surgical management of peritoneal carcinosis: Diagnosis, prevention and treatment","volume":"373","author":"Sugarbaker","year":"1988","journal-title":"Langenbecks Arch. Chir."},{"key":"10.1038\/s41379-022-01012-y_bib5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jamasurg.2013.3640","article-title":"Surgical outcomes of hyperthermic intraperitoneal chemotherapy: Analysis of the american college of surgeons national surgical quality improvement program","volume":"149","author":"Jafari","year":"2014","journal-title":"JAMA Surg."},{"key":"10.1038\/s41379-022-01012-y_bib6","doi-asserted-by":"crossref","first-page":"e186847","DOI":"10.1001\/jamanetworkopen.2018.6847","article-title":"Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures","volume":"2","author":"Foster","year":"2019","journal-title":"JAMA Netw. Open."},{"key":"10.1038\/s41379-022-01012-y_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/jso.20013","article-title":"Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy","volume":"85","author":"Verwaal","year":"2004","journal-title":"J. Surg. Oncol."},{"key":"10.1038\/s41379-022-01012-y_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejca.2015.09.017","article-title":"Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial","volume":"53","author":"Cashin","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1038\/s41379-022-01012-y_bib9","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J. Clin. Oncol.: Off J. Am. Soc. Clin. Oncol."},{"key":"10.1038\/s41379-022-01012-y_bib10","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ejso.2018.10.086","article-title":"A UNICANCER phase III trial of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Carcinomatosis. PRODIGE 7","volume":"45","author":"Quenet","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1038\/s41379-022-01012-y_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","article-title":"Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: Retrospective analysis of 523 patients from a multicentric French study","volume":"28","author":"Elias","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1038\/s41379-022-01012-y_bib12","article-title":"Mapping the spreading routes of lymphatic metastases in human colorectal cancer","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1038\/s41379-022-01012-y_bib13","doi-asserted-by":"crossref","first-page":"e0126670","DOI":"10.1371\/journal.pone.0126670","article-title":"Co-evolution of somatic variation in primary and metastatic colorectal cancer may expand biopsy indications in the molecular era","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One."},{"key":"10.1038\/s41379-022-01012-y_bib14","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.21037\/jtd.2018.10.72","article-title":"Mutational profile of colorectal cancer lung metastases and paired primary tumors by targeted next generation sequencing: implications on clinical outcome after surgery","volume":"10","author":"Schweiger","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"10.1038\/s41379-022-01012-y_bib15","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1245\/s10434-019-07923-6","article-title":"Gains of chromosome 1p and 15q are associated with poor survival after cytoreductive surgery and HIPEC for treating colorectal peritoneal metastases","volume":"26","author":"Enblad","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"10.1038\/s41379-022-01012-y_bib16","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1038\/s41379-022-01012-y_bib17","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1038\/s41379-022-01012-y_bib18","doi-asserted-by":"crossref","first-page":"e0182512","DOI":"10.1371\/journal.pone.0182512","article-title":"High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer","volume":"12","author":"Siesing","year":"2017","journal-title":"PLoS One."},{"key":"10.1038\/s41379-022-01012-y_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-8-78","article-title":"Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer","volume":"8","author":"Ehlen","year":"2010","journal-title":"J. Transl. Med."},{"key":"10.1038\/s41379-022-01012-y_bib20","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.18632\/oncotarget.23486","article-title":"Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification","volume":"9","author":"Karnevi","year":"2018","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-022-01012-y_bib21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/0284186X.2019.1691258","article-title":"Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: A population-based Scandinavian study","volume":"59","author":"Mezheyeuski","year":"2020","journal-title":"Acta. Oncol."},{"key":"10.1038\/s41379-022-01012-y_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1158\/0008-5472.CAN-15-3024","article-title":"Tumor heterogeneity\u2013A \u2018Contemporary Concept\u2019 founded on historical insights and predictions","volume":"76","author":"Welch","year":"2016","journal-title":"Cancer Res."},{"key":"10.1038\/s41379-022-01012-y_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-014-0454-7","article-title":"Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions","volume":"15","author":"Brannon","year":"2014","journal-title":"Genome Biol."},{"key":"10.1038\/s41379-022-01012-y_bib24","doi-asserted-by":"crossref","first-page":"eaay9691","DOI":"10.1126\/sciadv.aay9691","article-title":"The clonal evolution of metastatic colorectal cancer","volume":"6","author":"Dang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1038\/s41379-022-01012-y_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.aai8515","article-title":"Origins of lymphatic and distant metastases in human colorectal cancer","volume":"357","author":"Naxerova","year":"2017","journal-title":"Sci. (N. Y, N. Y)"},{"key":"10.1038\/s41379-022-01012-y_bib26","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.3748\/wjg.v22.i34.7692","article-title":"Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum","volume":"22","author":"Lemoine","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1038\/s41379-022-01012-y_bib27","doi-asserted-by":"crossref","unstructured":"Jayne, D. Molecular Biology of Peritoneal Carcinomatosis. In: Wim P. Ceelen (ed). Peritoneal Carcinomatosis: A Multidisciplinary Approachhttps:\/\/doi.org\/10.1007\/978-0-387-48993-3_2 21\u201333 (Springer US: Boston, MA, 2007).","DOI":"10.1007\/978-0-387-48993-3_2"},{"key":"10.1038\/s41379-022-01012-y_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-06807-3","article-title":"Chemotherapy, host response and molecular dynamics in periampullary cancer: The CHAMP study","volume":"20","author":"Hau","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1038\/s41379-022-01012-y_bib29","unstructured":"Cancer, A. J. C. o. AJCC CANCER STAGING MANUAL Seventh Edition. (Springer, 2010)."},{"key":"10.1038\/s41379-022-01012-y_bib30","unstructured":"Eurofins. https:\/\/eurofinsgenomics.eu\/en\/eurofins-genomics\/product-faqs\/next-generation-sequencing\/questions-on-inview-oncopanel-all-in-one\/ (2021)."},{"key":"10.1038\/s41379-022-01012-y_bib31","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1038\/s41379-022-01012-y_bib32","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/bioinformatics\/btv098","article-title":"Sambamba: fast processing of NGS alignment formats","volume":"31","author":"Tarasov","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1038\/s41379-022-01012-y_bib33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1038\/s41379-022-01012-y_bib34","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"key":"10.1038\/s41379-022-01012-y_bib35","doi-asserted-by":"crossref","first-page":"11189","DOI":"10.1093\/nar\/gks918","article-title":"LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets","volume":"40","author":"Wilm","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1038\/s41379-022-01012-y_bib36","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: The catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1038\/s41379-022-01012-y_bib37","doi-asserted-by":"crossref","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: Genome-wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput. Biol."},{"key":"10.1038\/s41379-022-01012-y_bib38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.21037\/tlcr.2018.08.14","article-title":"Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and clinicians","volume":"7","author":"Allg\u00e4uer","year":"2018","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1038\/s41379-022-01012-y_bib39","doi-asserted-by":"crossref","first-page":"661","DOI":"10.21037\/tlcr.2018.08.02","article-title":"Methods of measurement for tumor mutational burden in tumor tissue","volume":"7","author":"Mel\u00e9ndez","year":"2018","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1038\/s41379-022-01012-y_bib40","doi-asserted-by":"crossref","first-page":"D805","DOI":"10.1093\/nar\/gku1075","article-title":"COSMIC: Exploring the world's knowledge of somatic mutations in human cancer","volume":"43","author":"Forbes","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1038\/s41379-022-01012-y_bib41","doi-asserted-by":"crossref","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: Public archive of interpretations of clinically relevant variants","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1038\/s41379-022-01012-y_bib42","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: The NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1038\/s41379-022-01012-y_bib43","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1038\/s41379-022-01012-y_bib44","doi-asserted-by":"crossref","first-page":"e1005965","DOI":"10.1371\/journal.pcbi.1005965","article-title":"A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal","volume":"14","author":"Sun","year":"2018","journal-title":"PLoS Comput. Biol."},{"key":"10.1038\/s41379-022-01012-y_bib45","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1373\/clinchem.2014.223677","article-title":"Microsatellite instability detection by next generation sequencing","volume":"60","author":"Salipante","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1038\/s41379-022-01012-y_bib46","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/annonc\/mdt591","article-title":"Metastatic pattern in colorectal cancer is strongly influenced by histological subtype","volume":"25","author":"Hugen","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-022-01012-y_bib47","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1245\/s10434-015-4387-5","article-title":"Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study","volume":"22","author":"Go\u00e9r\u00e9","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1038\/s41379-022-01012-y_bib48","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/PAS.0b013e31821c3dae","article-title":"SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas","volume":"35","author":"Magnusson","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1038\/s41379-022-01012-y_bib49","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/bjc.2012.34","article-title":"A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer","volume":"106","author":"Eberhard","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1038\/s41379-022-01012-y_bib50","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41379-019-0265-1","article-title":"SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer","volume":"32","author":"Ma","year":"2019","journal-title":"Mod. Pathol."},{"key":"10.1038\/s41379-022-01012-y_bib51","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/PAI.0000000000000627","article-title":"A comprehensive evaluation of special AT-rich Sequence-binding Protein 2 (SATB2) immunohistochemical staining in mucinous tumors from gastrointestinal and nongastrointestinal sites","volume":"27","author":"Ramos","year":"2019","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1038\/s41379-022-01012-y_bib52","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/PAS.0000000000001159","article-title":"SATB2 Is superior to CDX2 in distinguishing signet ring cell carcinoma of the upper gastrointestinal tract and lower gastrointestinal tract","volume":"42","author":"Ma","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1038\/s41379-022-01012-y_bib53","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/prca.201100020","article-title":"High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer","volume":"5","author":"Hjelm","year":"2011","journal-title":"Proteom. Clin. Appl."},{"key":"10.1038\/s41379-022-01012-y_bib54","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/his.12726","article-title":"RBM3 expression loss is associated with right-sided localization and poor prognosis in colorectal cancer","volume":"68","author":"Melling","year":"2015","journal-title":"Histopathology"},{"key":"10.1038\/s41379-022-01012-y_bib55","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/jso.26375","article-title":"Clinical significance of RBM3 expression in surgically treated colorectal lung metastases and paired primary tumors","volume":"123","author":"Vidarsdottir","year":"2021","journal-title":"J. Surg. Oncol."},{"key":"10.1038\/s41379-022-01012-y_bib56","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1158\/1078-0432.CCR-14-0332","article-title":"Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: A pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies","volume":"20","author":"Venderbosch","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1038\/s41379-022-01012-y_bib57","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"The Cancer Genome Atlas Network","year":"2012","journal-title":"Nature."},{"key":"10.1038\/s41379-022-01012-y_bib58","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1200\/JCO.2018.36.4_suppl.616","article-title":"Impact of microsatellite instability (MSI) on tumor clonal evolution in metastatic colorectal cancer (mCRC)","volume":"36","author":"Willis","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1038\/s41379-022-01012-y_bib59","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1746-1596-9-126","article-title":"Heterogenous mismatch-repair status in colorectal cancer","volume":"9","author":"Joost","year":"2014","journal-title":"Diagn. Pathol."},{"key":"10.1038\/s41379-022-01012-y_bib60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/cjp2.120","article-title":"Heterogenous loss of mismatch repair (MMR) protein expression: A challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation","volume":"5","author":"McCarthy","year":"2019","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1038\/s41379-022-01012-y_bib61","article-title":"Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features","volume":"12","author":"Mendelaar","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1038\/s41379-022-01012-y_bib62","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1158\/1078-0432.CCR-14-2413","article-title":"Subclonal genomic architectures of primary and metastatic colorectal cancer based on intratumoral genetic heterogeneity","volume":"21","author":"Kim","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1038\/s41379-022-01012-y_bib63","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell."},{"key":"10.1038\/s41379-022-01012-y_bib64","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3389\/fonc.2019.00462","article-title":"PP2A: A promising biomarker and therapeutic target in endometrial cancer","volume":"9","author":"Remmerie","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1038\/s41379-022-01012-y_bib65","doi-asserted-by":"crossref","first-page":"eabe2967","DOI":"10.1126\/scitranslmed.abe2967","article-title":"Druggable cancer phosphatases","volume":"13","author":"Vainonen","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1038\/s41379-022-01012-y_bib66","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1158\/0008-5472.CAN-19-3468","article-title":"Extensive clonal branching shapes the evolutionary history of high-risk pediatric cancers","volume":"80","author":"Andersson","year":"2020","journal-title":"Cancer Res."},{"key":"10.1038\/s41379-022-01012-y_bib67","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cell.2018.03.043","article-title":"Deterministic evolutionary trajectories influence primary tumor growth: TRACERx Renal","volume":"173","author":"Turajlic","year":"2018","journal-title":"Cell."},{"key":"10.1038\/s41379-022-01012-y_bib68","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","article-title":"Tracking the evolution of non-small-cell lung cancer","volume":"376","author":"Jamal-Hanjani","year":"2017","journal-title":"N. Engl. J. Med."}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01012-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01012-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222000886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222000886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01012-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:29:11Z","timestamp":1760228951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222000886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0893395222000886"],"URL":"https:\/\/doi.org\/10.1038\/s41379-022-01012-y","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delineating the intra-patient heterogeneity of molecular alterations in treatment-na\u00efve colorectal cancer with peritoneal carcinomatosis","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-022-01012-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}]}}